Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAtlantic Lithium Regulatory News (ALL)

Share Price Information for Atlantic Lithium (ALL)

Share Price is delayed by 15 minutes
Get Live Data
16.25    -0.10 (-0.61%)
Bid:
16.25
Ask:
16.35
Spread: 0.10 (0.615%)
Market Cap: £130.24m
ALL Live PriceLast checked at - London Stock Exchange

Intraday Atlantic Lithium Share Chart

Scrip Dividend Scheme

14 Nov 2013 17:34

RNS Number : 0975T
Allocate Software PLC
14 November 2013
 



14 November 2013

 

ALLOCATE SOFTWARE PLC

("Allocate" or "the Company")

 

 

Scrip Dividend Scheme

 

The Board of Allocate Software plc (the "Company") confirmed in an announcement on 31 July 2013 that a scrip alternative to the forthcoming final dividend will be available to shareholders under the terms of the Company's Scrip Dividend Scheme (the "Scheme").

 

The scrip calculation price in relation to the final dividend due to be paid on 5 December 2013 is 106.9p per share. This is the average of the closing middle-market quotations for the Company's ordinary shares as derived from the London Stock Exchange Daily Official List for the five dealing days commencing on the ex-dividend date 6 November 2013.

 

Shareholders wishing to participate in the Scheme (unless they have already elected to do so) should submit a completed Scrip Mandate Form to the Share Registrar, Capita Asset Services, by 5.00pm on 15 November 2013. Scrip Mandate Forms are available from the Share Registrar by calling 0871 664 0300 from within the UK and +44 20 8639 3399 if calling from outside the UK, subject to standard UK or international charges as applicable.

 

Alternatively, shareholders can elect to participate online via the Capita Share Portal at www.capitashareportal.com. Shareholders who hold shares in uncertificated form in CREST should submit elections via CREST by 5.00pm on 15 November 2013. Shareholders wishing to revoke previously submitted Scrip Mandate Forms should also contact the Share Registrar by 5.00pm on 15 November 2013.

 

Full details of the Scheme are available on the Company's website, www.allocatesoftware.com.

 

 

Enquiries:

Allocate Software plc

Chris Gale - Chief Financial Officer

Tel: +44 (0) 20 7355 5555

Numis Securities

Nominated adviser - Simon Willis / Richard Thomas

Corporate Broking - James Black

 

Tel: +44 (0) 20 7260 1000

Gable Communications

Justine James

 

Tel: +44 (0) 20 7193 7463

+44 (0) 7525 324 431

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCGGGBPGUPWGMC
Date   Source Headline
23rd Nov 20239:39 amRNSUpdated Quarterly Activities and Cash Flow Report
22nd Nov 20237:00 amRNSProject Development Update
16th Nov 20237:00 amRNSInvestor Presentation - Noosa Mining Conference
15th Nov 20237:00 amRNSRejection of Non-Binding Indicative Offers
14th Nov 20237:00 amRNSGrant of Highly Prospective Licences for Lithium
10th Nov 20237:00 amRNSConference Attendance
7th Nov 20237:00 amRNSAdditional Resource Extension Drilling Planned
1st Nov 20237:00 amRNSChange of Registered Office
31st Oct 20237:05 amRNSNotice of AGM
31st Oct 20237:00 amRNSQuarterly Activities and Cash Flow Report
20th Oct 20237:00 amRNSMining Lease Granted for Ewoyaa Lithium Project
19th Oct 202311:35 amRNSStatement re Media Speculation
13th Oct 20237:00 amRNSConference Attendance
10th Oct 20237:00 amRNSApproval to Divert Transmission Lines at Ewoyaa
29th Sep 20239:55 amRNSInvestor Presentation
28th Sep 20237:00 amRNS2023 Annual Financial Report
21st Sep 20237:00 amRNSNotice of Results and Investor Presentation
15th Sep 20237:00 amRNSConference Attendance
8th Sep 20237:05 amRNSInvestor Presentation
8th Sep 20237:00 amRNSUS$32.9m Strategic Investment
6th Sep 20237:00 amRNSResource and Exploration Drilling Results
4th Sep 20238:45 amRNSConference Attendance
30th Aug 20237:00 amRNSIssue of Equity - ESOP Options
22nd Aug 20237:00 amRNSIssue of Equity - Exercise of ESOP Options
17th Aug 20237:00 amRNSPartner Commits to Ewoyaa Development Funding
15th Aug 20237:00 amRNSMOU Signed for By-product Feldspar Study
10th Aug 20239:14 amRNSPCA Dealings
9th Aug 20239:30 amRNSDirector/PDMR Dealings
8th Aug 20237:00 amRNSResource and Exploration Drilling Results
7th Aug 20233:13 pmRNSStatement re Media Speculation
31st Jul 20237:00 amRNSQuarterly Activities and Cash Flow Report
19th Jul 20237:00 amRNSConference Attendance
13th Jul 20237:00 amRNSAppointment of Flotation Scoping Study Partner
30th Jun 20237:00 amRNSInvestor Presentation
29th Jun 20238:21 amRNSEwoyaa Definitive Feasibility Study
29th Jun 20237:17 amRNSEwoyaa Definitive Feasibility Study
23rd Jun 202311:00 amRNSBoard Appointments
20th Jun 20237:00 amRNSInitial Infill Drilling Results
16th Jun 20237:00 amRNSConference Attendance
13th Jun 20237:00 amRNSCorporate Update - Resignation of Director
1st Jun 20237:00 amRNSBoard Changes
26th May 20237:00 amRNSDTC Eligibility for OTCQX Electronic Trading
17th May 20237:00 amRNSConference Attendance
16th May 20237:00 amRNSAppointment of Chief Executive Officer
4th May 20237:00 amRNSConference Attendance
28th Apr 20237:00 amRNSQuarterly Activities and Cash Flow Report
26th Apr 20237:00 amRNSInternational Lithium Association Membership
19th Apr 20237:00 amRNSInfill Drilling and Passive Seismic Survey
6th Apr 20237:00 amRNSIssue of Equity – Exercise of ESOP Options
31st Mar 20237:00 amRNSIssue of Options

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.